George A. Scangos - 17 Oct 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Sung Lee, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
17 Oct 2023
Net transactions value
$0
Form type
4
Filing time
18 Oct 2023, 14:14:37 UTC
Previous filing
18 Sep 2023
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -1,750,000 -91% $0.000000 168,489 17 Oct 2023 Direct F1
transaction VIR Common Stock Other $0 +1,750,000 $0.000000 1,750,000 17 Oct 2023 See footnote F1, F2
transaction VIR Common Stock Other $0 -1,750,000 -100% $0.000000* 0 17 Oct 2023 See footnote F1, F3
transaction VIR Common Stock Other $0 +1,750,000 $0.000000 1,750,000 17 Oct 2023 See footnote F1, F4
holding VIR Common Stock 33,629 17 Oct 2023 See footnote F5
holding VIR Common Stock 179,930 17 Oct 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
F3 The shares are held by the spouse of the reporting person.
F4 The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
F5 The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
F6 The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.